Biotech Exec Settles Over Trades Ahead Of Novartis Deal
A former manager at Array BioPharma Inc., a Colorado-based developer of cancer drugs, agreed Monday to settle allegations brought by the U.S. Securities and Exchange Commission that he illegally traded on...To view the full article, register now.
Already a subscriber? Click here to view full article